Emily Newton, Revolutionized Magazine

IoT: The Next Big Thing in Precision Lab Equipment

By Emily Newton

…the window for error. The immediate connectivity ensures timely entry of the most critical research points. Interoperability grows if the lab IoT integrates with additional assets, such as big data…

…the window for error. The immediate connectivity ensures timely entry of the most critical research points. Interoperability grows if the lab IoT integrates with additional assets, such as big data…

Continue reading

Ashwini Sharan

Closed-Loop Technologies Reduce the Burden of Chronic Pain

By MedTech Intelligence Staff

…technology perspective has always been ‘what are the brain and spinal cord doing, and can we record that?’ That’s the big challenge that engineering had to figure out—how to filter…

…technology perspective has always been ‘what are the brain and spinal cord doing, and can we record that?’ That’s the big challenge that engineering had to figure out—how to filter…

Continue reading

Regulations

Regulatory Advocacy: Amplifying Your Voice

By MedTech Intelligence Staff

…thing is, if want to present your opinion, make sure it is data driven. More and more the agency is relying on data—even big data—so if you can present evidence…

…thing is, if want to present your opinion, make sure it is data driven. More and more the agency is relying on data—even big data—so if you can present evidence…

Continue reading

Karandeep Badwal

Preparing for EU MDR Post Market Reporting

By MedTech Intelligence Staff

EU MDR continues to pose challenges as companies prepare to recertify devices and bring new technologies to the European market. One of the big changes in the regulatory framework of…

EU MDR continues to pose challenges as companies prepare to recertify devices and bring new technologies to the European market. One of the big changes in the regulatory framework of…

Continue reading

Megan Coder

Bringing Digital Health Products to the Global Market

By MedTech Intelligence Staff

…to conduct. Validation is central and critical to everything these companies do and the lack of guidance on where to head with that is a big challenge. Additionally, applicability of…

…to conduct. Validation is central and critical to everything these companies do and the lack of guidance on where to head with that is a big challenge. Additionally, applicability of…

Continue reading

Doug Donahue

Ask the Expert: Four Key Reasons Medical Device Manufacturers Should Be Looking at Mexico

…the least. The Trump administration imposed tariffs on goods imported from China and the Biden administration has yet to remove those tariffs. Mexico has a big advantage in terms of…

…the least. The Trump administration imposed tariffs on goods imported from China and the Biden administration has yet to remove those tariffs. Mexico has a big advantage in terms of…

Continue reading

Harsha Rajasimha, Ph.D.

AI and the Lack of Diversity in Data: Implications and the Path Forward for Rare Disease Research

By MedTech Intelligence Staff

…also been seeking to establish a global clinical trial network. What we are suggesting is that data scientists understand that it’s not the algorithm that’s a big deal, it’s the…

…also been seeking to establish a global clinical trial network. What we are suggesting is that data scientists understand that it’s not the algorithm that’s a big deal, it’s the…

Continue reading

Cybersecurity

Preparing for the PATCH Act and RTA

By MedTech Intelligence Staff

…retrievable. Companies, in general, don’t do a great job at post-market cybersecurity monitoring. So, the biggest change and challenge is in looking at products you’ve had in the market for…

…retrievable. Companies, in general, don’t do a great job at post-market cybersecurity monitoring. So, the biggest change and challenge is in looking at products you’ve had in the market for…

Continue reading

Jennifer Geetter

Successful Development, Approval and Deployment of Digital Health Solutions

By Jennifer Geetter

…But for life sciences companies, this can be a big of a development mind shift. Identifying the features and functionalities that should be monitored and redeployed is part of success,…

…But for life sciences companies, this can be a big of a development mind shift. Identifying the features and functionalities that should be monitored and redeployed is part of success,…

Continue reading